Skip to main content
. 2005 Jun;49(6):2367–2371. doi: 10.1128/AAC.49.6.2367-2371.2005

FIG. 1.

FIG. 1.

Time-concentration curves (means ± SDs) of linezolid in plasma (total and free) and ISF of subcutaneous adipose tissue and skeletal muscle. (a) Profile after administration of a single intravenous dose of 600 mg (n = 10); (b) concentration-versus-time profile after multiple doses of oral linezolid intake (600 mg twice a day; n = 9).